dockets: FDA-2004-D-0366
This data as json
| id | agency_id | title | docket_type | last_modified | object_id |
|---|---|---|---|---|---|
| FDA-2004-D-0366 | FDA | International Conference on Harmonisation; Draft Guidance on S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals | Nonrulemaking | 2021-09-01T01:02:19Z | 0b0000648047367c |
Links from other tables
- 6 rows from docket_id in documents